With its explosion on Tuesday following a blowout earnings report, Palantir (NASDAQ: PLTR) crossed a market cap of $200 billion for the first time. The company is now one of the most valuable software ...
JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...
Australia's S&P/ASX 200 slid just 0.04% to 8,517.20. South Korea's Kospi declined 0.23% to 2,530.79. Hong Kong's Hang Seng rose 1.35% to 31,173.35, while the Shanghai Composite was up 1.33% to ...
BSE Sensex and Nifty50, the Indian equity benchmark indices, ended in red today. While BSE Sensex went below the 77,600 mark, ...
Palantir (NASDAQ: PLTR) came into its fourth-quarter earnings report with its shares priced to perfection, but the AI stock ...
L'Oreal shares fell 4% as the French cosmetics giant reported slower-than-forecast fourth-quarter sales. Porsche stock fell 5 ...
Shares of the artificial intelligence (AI) chip leader have been crushed this year, but recent developments suggest the best ...
We recently published a list of 15 Hot Tech Stocks to Buy Right Now. In this article, we are going to take a look at where ...
Citi analyst Peter Christiansen upgraded Pagaya Technologies (NASDAQ:PGY) from Neutral to Buy, adjusting the price target to $14.50, up from the previous $13.00. The stock has shown strong momentum, ...
Investors initiated a massive Nvidia stock selloff upon the release of DeepSeek, but here's why the Chinese AI might actually ...
AMD's (NASDAQ: AMD) data center growth failed to impress investors. *Stock prices used were the afternoon prices of Feb. 3, ...
Palantir Technologies (NASDAQ: PLTR) was the best-performing member of the S&P 500 (SNPINDEX: ^GSPC) in 2024, and the company carried that momentum into 2025. Earlier this week, Palantir announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results